找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: HMG-CoA Reductase Inhibitors; Gerd Schmitz,Michael Torzewski Book 2002 Springer Basel AG 2002 atherosclerosis.cardiovascular.coronary arte

[復(fù)制鏈接]
樓主: 指責(zé)
21#
發(fā)表于 2025-3-25 05:03:52 | 只看該作者
22#
發(fā)表于 2025-3-25 08:41:54 | 只看該作者
23#
發(fā)表于 2025-3-25 11:44:58 | 只看該作者
Michael D. Robinson,Michael Eid hypercholesterolemia [.]. Clinical trials have demonstrated that they can induce regression of vascular atherosclerosis, as well as reduction of cardiovascular-related morbidity and mortality, in patients with and without coronary artery disease CAD [.–.]. These trials provide a powerful endorsemen
24#
發(fā)表于 2025-3-25 17:22:12 | 只看該作者
Swarup Bhunia,Mark M.‘Tehranipoortible to rupture or fissuring, thereby being a focus of high risk for thrombus formation. Rupture with consecutive thrombus formation can cause an acute coronary syndrome, such as unstable angina or myocardial infarction. So far reduction of plasma cholesterol by lipid-lowering therapy has been show
25#
發(fā)表于 2025-3-25 22:26:03 | 只看該作者
26#
發(fā)表于 2025-3-26 00:57:08 | 只看該作者
27#
發(fā)表于 2025-3-26 04:37:57 | 只看該作者
28#
發(fā)表于 2025-3-26 08:42:03 | 只看該作者
Sterol-regulatory element binding proteins (SREBPs): gene-regulatory target of statin action,tible to rupture or fissuring, thereby being a focus of high risk for thrombus formation. Rupture with consecutive thrombus formation can cause an acute coronary syndrome, such as unstable angina or myocardial infarction. So far reduction of plasma cholesterol by lipid-lowering therapy has been show
29#
發(fā)表于 2025-3-26 13:37:23 | 只看該作者
30#
發(fā)表于 2025-3-26 18:28:43 | 只看該作者
Cost-effectiveness of statins in primary and secondary prevention of coronary heart disease,as the elderly, will also be considered. In addition, we will also consider the relative cost-effectiveness of different statin therapies. Finally, we will consider the cost-effectiveness of statin therapy and resource utilisation in relation to healthcare provision.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-5 05:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
正安县| 顺昌县| 乌兰察布市| 普安县| 汕头市| 资源县| 麻城市| 金门县| 紫金县| 涿州市| 九龙坡区| 庆云县| 宁晋县| 天门市| 关岭| 灵宝市| 独山县| 鲁山县| 武威市| 中阳县| 鹤壁市| 郑州市| 全南县| 西充县| 康乐县| 台湾省| 三河市| 静安区| 宜章县| 富顺县| 改则县| 察隅县| 石阡县| 雅江县| 大邑县| 南乐县| 临颍县| 建宁县| 威宁| 牟定县| 武宣县|